Comparison of Two Pediatric-Inspired Regimens to Hyper-CVAD in Hispanic Adolescents and Young Adults With Acute Lymphoblastic Leukemia.

作者: Emmanuel Almanza-Huante , Karla Espinosa-Bautista , Juan Rangel-Patiño , Roberta Demichelis-Gómez

DOI: 10.1016/J.CLML.2020.07.017

关键词: Hyper-CVADYoung adultRetrospective cohort studyInternal medicineHazard ratioIncidence (epidemiology)TransplantationCohortPopulationMedicine

摘要: Abstract Background Pediatric-inspired regimens (PIR) in adolescents and young adults with acute lymphoblastic leukemia have led to better long-term outcomes. In Latin America, the adolescent adult population has an increasing incidence of poor outcomes (5-year OS approximately 20%) traditional regimens. Patients Methods A retrospective cohort study was performed patients treated PIR two reference centers Mexico City between March 2016 June 2019, which primary endpoint OS, compared a historic hyper-CVAD February 2009 June 2015. Results We 73 (46 27 received modified versions ALL-BFM 90 CALGB C10403 regimens, respectively) 173 hyper-CVAD. experienced higher 4-week complete response rates (79.5% vs. 64.2%; P = .02) lower relapse (44.1% 60.0%; P = .04). significantly than (24 months: 41.5% 28.1%; .012). The benefit on for only significant (24-month OS: 61.1% 28.0%; .01) but not BFM. multivariate analysis, hyperleukocytosis (hazard ratio [HR] = 1.90; 95% confidence interval [CI], 1.11-3.22; .02), autologous stem-cell transplantation (HR = 0.38; CI, 0.17-0.86; 0.43; 0.26-0.70; P  Conclusion terms response, rates, provides benefits Hispanic patients.

参考文章(44)
Martha Alvarado-Ibarra, Crescencio Mauricio González-Avante, Manuel Antonio López-Hernández, Rosa María Jiménez-Alvarado, José Enrique De Diego-Flores, Adolescentes con leucemia aguda linfoblástica de novo: eficacia y seguridad de un protocolo pediátrico versus uno de adultos Gaceta Medica De Mexico. ,vol. 144, pp. 485- 490 ,(2008)
Jessica L. Barrington-Trimis, Myles Cockburn, Catherine Metayer, W. James Gauderman, Joseph Wiemels, Roberta McKean-Cowdin, Rising rates of acute lymphoblastic leukemia in Hispanic children: trends in incidence from 1992 to 2011. Blood. ,vol. 125, pp. 3033- 3034 ,(2015) , 10.1182/BLOOD-2015-03-634006
Oscar Garcés-Ruiz, Arnulfo Nava-Zavala, Benjamín Rubio-Jurado, Lilia Aguilar-López, Rosbiney Díaz-Ruiz, Arturo Vega-Ruiz, Análisis de características clinicobiológicas de leucemia aguda linfoblástica (LAL) del adulto Gaceta Medica De Mexico. ,vol. 151, pp. 150- 156 ,(2015)
Michael E. Rytting, Elias J. Jabbour, Susan M. O'Brien, Hagop M. Kantarjian, Acute lymphoblastic leukemia in adolescents and young adults Cancer. ,vol. 123, pp. 2398- 2403 ,(2017) , 10.1002/CNCR.30624
Hagop M. Kantarjian, Susan O’Brien, Terry L. Smith, Jorge Cortes, Francis J. Giles, Miloslav Beran, Sherry Pierce, Yang Huh, Michael Andreeff, Charles Koller, Chul S. Ha, Michael J. Keating, Sharon Murphy, Emil J. Freireich, Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia Journal of Clinical Oncology. ,vol. 18, pp. 547- 561 ,(2000) , 10.1200/JCO.2000.18.3.547
F Hayakawa, , T Sakura, T Yujiri, E Kondo, K Fujimaki, O Sasaki, J Miyatake, H Handa, Y Ueda, Y Aoyama, S Takada, Y Tanaka, N Usui, S Miyawaki, S Suenobu, K Horibe, H Kiyoi, K Ohnishi, Y Miyazaki, S Ohtake, Y Kobayashi, K Matsuo, T Naoe, Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group Blood Cancer Journal. ,vol. 4, ,(2014) , 10.1038/BCJ.2014.72
Wendy Stock, Mei La, Ben Sanford, Clara D Bloomfield, James W Vardiman, Paul Gaynon, Richard A Larson, James Nachman, None, What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. ,vol. 112, pp. 1646- 1654 ,(2008) , 10.1182/BLOOD-2008-01-130237
Richard C. Harvey, Charles G. Mullighan, I-Ming Chen, Walker Wharton, Fady M. Mikhail, Andrew J. Carroll, Huining Kang, Wei Liu, Kevin K. Dobbin, Malcolm A. Smith, William L. Carroll, Meenakshi Devidas, W. Paul Bowman, Bruce M. Camitta, Gregory H. Reaman, Stephen P. Hunger, James R. Downing, Cheryl L. Willman, Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia Blood. ,vol. 115, pp. 5312- 5321 ,(2010) , 10.1182/BLOOD-2009-09-245944
Richard C. Harvey, Charles G. Mullighan, Xuefei Wang, Kevin K. Dobbin, George S. Davidson, Edward J. Bedrick, I-Ming Chen, Susan R. Atlas, Huining Kang, Kerem Ar, Carla S. Wilson, Walker Wharton, Maurice Murphy, Meenakshi Devidas, Andrew J. Carroll, Michael J. Borowitz, W. Paul Bowman, James R. Downing, Mary Relling, Jun Yang, Deepa Bhojwani, William L. Carroll, Bruce Camitta, Gregory H. Reaman, Malcolm Smith, Stephen P. Hunger, Cheryl L. Willman, Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. ,vol. 116, pp. 4874- 4884 ,(2010) , 10.1182/BLOOD-2009-08-239681
Inci Alacacioglu, Serife S. Medeni, Guner H. Ozsan, Bahriye Payzin, O. Gokmen Sevindik, Celal Acar, Abdullah Katgi, Fusun Ozdemirkan, Ozden Piskin, Mehmet A. Ozcan, Bulent Undar, Fatih Demirkan, Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers Chemotherapy. ,vol. 60, pp. 219- 223 ,(2015) , 10.1159/000375258